Hetero Launches Generic Breast Cancer Treatment Drug Hertab in India
Oncology Division
Share:
11. Jan. 2019

Hetero Launches Generic Breast Cancer Treatment Drug in India

Hetero has launched generic Lapatinib tablets, used in the treatment of advanced or metastatic breast cancer in the country. The tablets, under the brand name 'Hertab', have been launched in the strength of 250 mg, the product is marketed and distributed by Hetero Healthcare Ltd and has been made available in two stock keeping units (SKUs).The tablets are used in combination with Capecitabine or Letrozole, which together inhibit the growth of cancer cells in patient.

You Might Also Like

Would you like to share your thoughts?

Your email address & phone will not be published. Required fields are marked *


Comments

Williamadedy

31.Jul.2021

mature dating anr dating